A carregar...

Drift in Susceptibility of Neisseria gonorrhoeae to Ciprofloxacin and Emergence of Therapeutic Failure

Ciprofloxacin, 500 mg, was introduced as the first-line therapy for gonorrhea at St. Mary’s Hospital, London, in 1989, when a surveillance program was initiated to detect the emergence of resistance. Isolates of Neisseria gonorrhoeae from consecutive patients attending the Jefferiss Wing, Genitourin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ison, Catherine A., Woodford, Patricia J., Madders, Helen, Claydon, Elizabeth
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 1998
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC105966/
https://ncbi.nlm.nih.gov/pubmed/9797226
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!